Inventor · disambiguated record
Leslie S. Johnson
Also filed as: JOHNSON LESLIE · JOHNSON LESLIE S · JOHNSON LESLIE SYDNOR
101 granted patents·50 pending applications·1,550 citations·filing 1998–2025
99Inventor score
Top patents by PatentIndex Score
151 records- 0198US7553489B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2006·Granted Jun 30, 2009·44 cites·18 claims
- 0297US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0397US8802091B2Antibodies reactive with B7-H3 and uses thereofJOHNSON LESLIE S·Filed 2012·Granted Aug 12, 2014·54 cites·10 claims
- 0497US8216579B2Humanized FcγRIIB-specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2010·Granted Jul 10, 2012·43 cites·16 claims
- 0597US7786270B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2007·Granted Aug 31, 2010·55 cites·5 claims
- 0697US7521542B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2005·Granted Apr 21, 2009·105 cites·8 claims
- 0796US10131713B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Nov 20, 2018·10 cites·20 claims
- 0896US9587021B2CD3-binding molecules capable of binding to human and non-human CD3HUANG LING·Filed 2012·Granted Mar 7, 2017·45 cites·24 claims
- 0996US9150656B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofJOHNSON LESLIE S·Filed 2011·Granted Oct 6, 2015·47 cites·28 claims
- 1096US8802093B2HER2/neu-specific antibodies and methods of using sameJOHNSON LESLIE S·Filed 2009·Granted Aug 12, 2014·33 cites·15 claims
- 1196US8133982B2FcγRIIB specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2009·Granted Mar 13, 2012·54 cites·13 claims
- 1296US7847082B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2009·Granted Dec 7, 2010·26 cites·33 claims
- 1396US7351803B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2003·Granted Apr 1, 2008·78 cites·18 claims
- 1496US7112439B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2004·Granted Sep 26, 2006·78 cites·27 claims
- 1595US11623959B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2020·Granted Apr 11, 2023·6 cites·23 claims
- 1695US10633440B2Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigensMACROGENICS INC·Filed 2015·Granted Apr 28, 2020·11 cites·18 claims
- 1795US10577422B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 3, 2020·19 cites·10 claims
- 1895US10160806B2Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereofMACROGENICS INC·Filed 2015·Granted Dec 25, 2018·18 cites·34 claims
- 1995US9896508B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2016·Granted Feb 20, 2018·8 cites·12 claims
- 2095US9469692B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Oct 18, 2016·8 cites·14 claims
- 2195US9284375B2Covalent diabodies and uses thereofJOHNSON LESLIE S·Filed 2009·Granted Mar 15, 2016·31 cites·12 claims
- 2294US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 2394US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 2494US9243069B2HER2/neu-specific antibodies and methods of using the sameMACROGENICS INC·Filed 2014·Granted Jan 26, 2016·13 cites·9 claims
- 2594US7700735B2High potency recombinant antibodies and method for producing themMEDIMMUNE LLC·Filed 2001·Granted Apr 20, 2010·57 cites·38 claims
- 2694US7700100B2FcγRIIB fusion proteins and compositions thereofMACROGENICS INC·Filed 2004·Granted Apr 20, 2010·54 cites·4 claims
- 2794US7635568B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2004·Granted Dec 22, 2009·39 cites·95 claims
- 2894US7618628B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 17, 2009·22 cites·23 claims
- 2993US11858991B2LAG-3-binding molecules and methods of use thereofMACROGENICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·18 claims
- 3093US11111299B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2018·Granted Sep 7, 2021·3 cites·31 claims
- 3193US9441049B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Sep 13, 2016·10 cites·11 claims
- 3293US9296816B2Covalent diabodies and uses thereofJOHNSON LESLIE S·Filed 2006·Granted Mar 29, 2016·18 cites·36 claims
- 3393US9096877B2Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their useJOHNSON LESLIE S·Filed 2010·Granted Aug 4, 2015·47 cites·16 claims
- 3493US8795667B2Compositions for the prevention and treatment of smallpoxJOHNSON LESLIE S·Filed 2008·Granted Aug 5, 2014·13 cites·19 claims
- 3593US7572456B2Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereofMACROGENICS INC·Filed 2005·Granted Aug 11, 2009·21 cites·19 claims
- 3693US6833356B1Pneumococcal protein homologs and fragments for vaccinesMEDIMMUNE INC·Filed 2000·Granted Dec 21, 2004·42 cites·8 claims
- 3792US10150812B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2017·Granted Dec 11, 2018·9 cites·28 claims
- 3892US10093738B2Covalent diabodies and uses thereofMACROGENICS INC·Filed 2016·Granted Oct 9, 2018·7 cites·15 claims
- 3992US9695236B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2015·Granted Jul 4, 2017·11 cites·19 claims
- 4092US7838635B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 23, 2010·17 cites·19 claims
- 4192US7740851B2Ultra high affinity neutralizing antibodiesMEDIMMUNE LLC·Filed 2003·Granted Jun 22, 2010·35 cites·32 claims
- 4291US11421031B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·22 claims
- 4391US11028183B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2018·Granted Jun 8, 2021·3 cites·38 claims
- 4491US9889197B2Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albuminJOHNSON LESLIE S·Filed 2011·Granted Feb 13, 2018·13 cites·12 claims
- 4591US9714296B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·7 cites·27 claims
- 4691US8663634B2Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicityKOENIG SCOTT·Filed 2006·Granted Mar 4, 2014·25 cites·12 claims
- 4790US9714295B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·6 cites·27 claims
- 4890US8784808B2FcγRIIB specific antibodies and methods of use thereofJOHNSON LESLIE S·Filed 2012·Granted Jul 22, 2014·13 cites·25 claims
- 4990US8153133B2High potency recombinant antibodies and method for producing themYOUNG JAMES F·Filed 2010·Granted Apr 10, 2012·20 cites·30 claims
- 5089US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Leslie S. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →